PitchCentric
Innovation to Impact: Drug Development, AI, and Regulatory Strategy
Updated 8 days ago Β· Refreshed hourly
Businesslife

Innovation to Impact: Drug Development, AI, and Regulatory Strategy

Hosted by Unknown Host Β· πŸ‡ΊπŸ‡Έ US Β· EN Β· 6 episodes

Where this show ranks

Episodes
6
Last ep.
12 days ago
Avg length
31m
Booking Probabilityβ„’
27
Stretch.
Sign in to score against your profile.
Estimated audience
,
Audience size not yet estimated
Listen Score
12
Niche reach.
Virality (30d)
44
Steady cadence.

Pitch Analysis

Sign in to see how your Guest Score compares to this show's Required Pod Score and get a Stretch / Match-fit / Anchor verdict.
Required Pod Score
80/ 100
Premium

Established thought leaders with verified media credentials.

Contact path
Verified email on file
Unlock verified contacts
Guest openness
Not signalled recently
Best topics to pitch
BusinessManagementScienceLife

About this podcast

Innovation to Impact is a podcast on decision-grade drug development in regulated environments. We examine how high-stakes go/no-go calls are made inside pharma and biotech, and what evidence is required for new tools to change those decisions without creating hidden risk. Each episode focuses on predictivity, translational risk, decision rights, and accountability (what breaks, who owns it, and what triggers a stop). This is not a podcast about technology trends. It is about disciplined innovation that can survive audit, scale, and real-world biology.

BusinessManagementScienceLife

About the host

Unknown Host hosts Innovation to Impact: Drug Development, AI, and Regulatory Strategy, a business show with 6 episodes published.

Verified host email:β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ@β–ˆβ–ˆβ–ˆβ–ˆ.comSign in to unlock β†’

Recent episodes

Our AI reads these to draft pitches

De-Risking What Matters

May 19, 202637mEp. 2S2

In this episode of Innovation to Impact: Ruminations & Ramblings, Szczepan Baran, Brian Berridge, and Nick Kelley tackle one of the biggest problems in modern drug development: we keep adding more technology, more data,

Show notes

Innovation That Earns Deletion (Subtractive Trust)

Feb 15, 202633mEp. 1S2

Click here to watch a video of this episode. Drug development workflows only get heavier, and subtractive change requires predictivity and decision-grade evidence that can survive regulatory science scrutiny. In this epi

Show notes

Biology, Loops, and Decision-Grade Trust

Feb 15, 202629mEp. 4S1

Click here to watch a video of this episode. In drug development, go/no-go decisions concentrate translational risk and expose real consequences. When AI or digital biomarkers influence that call, decision-grade evidence

Show notes

Rethinking Return in Drug Development

Feb 15, 202629mEp. 3S1

Click here to watch a video of this episode. In drug development, ROI debates can drown out decision-grade evidence and the hard work of translational science. This episode asks a blunt question: when AI, digital biomark

Show notes

Predictivity Is the New Currency of Drug Development

Feb 15, 202623mEp. 2S1

Click here to watch a video of this episode. Drug development punishes optimism, and predictivity is one of the few defenses we have against translational risk. In this episode we connect translational science and regula

Show notes

Patients First. Platforms Second

Feb 15, 202635mEp. 1S1

Click here to watch a video of this episode. In drug development, translational science can generate endless options, but decision-grade evidence starts with the patient decision. This episode looks at why AI and digital

Show notes

Sponsors and advertisers

Sponsor detection runs nightly. Check back soon.

Audience demographics

Age
25-54
Consumer type
Professionals & Founders

Topics covered

BusinessManagementScienceLife

Successful pitch examples

No public pitch examples yet for this show.

Generate your own personalised pitch

If you're pitching Innovation to Impact: Drug Development, AI, and Regulatory Strategy, also consider

Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.

Frequently asked questions

How do I pitch Innovation to Impact: Drug Development, AI, and Regulatory Strategy as a podcast guest?

Innovation to Impact: Drug Development, AI, and Regulatory Strategy has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their business audience.

Who is the host of Innovation to Impact: Drug Development, AI, and Regulatory Strategy?

Innovation to Impact: Drug Development, AI, and Regulatory Strategy is hosted by Unknown Host. The show is categorised under Business (life) and has published 6 episodes.

How many episodes does Innovation to Impact: Drug Development, AI, and Regulatory Strategy have?

Innovation to Impact: Drug Development, AI, and Regulatory Strategy has published 6 episodes.

What topics does Innovation to Impact: Drug Development, AI, and Regulatory Strategy cover?

Innovation to Impact: Drug Development, AI, and Regulatory Strategy regularly covers Business, Management, Science, Life. It sits in the Business category, with a life focus.

Is it hard to get booked on Innovation to Impact: Drug Development, AI, and Regulatory Strategy?

Innovation to Impact: Drug Development, AI, and Regulatory Strategy is accessible for guests with genuine business expertise. A personalised, episode-aware pitch will still outperform a generic one every time.

Is Innovation to Impact: Drug Development, AI, and Regulatory Strategy currently accepting guest pitches?

Innovation to Impact: Drug Development, AI, and Regulatory Strategy hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.

How long are Innovation to Impact: Drug Development, AI, and Regulatory Strategy episodes?

Episodes of Innovation to Impact: Drug Development, AI, and Regulatory Strategy average 31 minutes. a focused format where a clear narrative arc and tight preparation matter most.

What guest credentials does Innovation to Impact: Drug Development, AI, and Regulatory Strategy typically look for?

Our data rates Innovation to Impact: Drug Development, AI, and Regulatory Strategy's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.

Methodology. Booking Probabilityβ„’ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 8 days ago.

Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.